sorafenib has been researched along with silicon in 5 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (silicon) | Trials (silicon) | Recent Studies (post-2010) (silicon) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 13,461 | 71 | 6,740 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Airaksinen, AJ; Hirvonen, JT; Kaasalainen, MH; Liu, D; Mäkilä, EM; Salonen, JJ; Santos, HA; Sarparanta, MP; Wang, CF | 1 |
Hagström, MV; Hirvonen, JT; Kaasalainen, MH; Mäkilä, EM; Salonen, JJ; Santos, HA; Wang, CF | 1 |
Airaksinen, AJ; Hirvonen, JT; Hyvönen, ML; Laakkonen, PM; Mäkilä, EM; Salonen, JJ; Santos, HA; Sarparanta, MP; Wang, CF | 1 |
Almeida, S; Correia, A; Hirvonen, J; Mäkilä, E; Salonen, J; Santos, HA; Shahbazi, MA | 1 |
Almeida, PV; Correia, A; Herranz-Blanco, B; Hirvonen, J; Mäkilä, E; Salonen, J; Santos, HA; Shahbazi, MA; Shrestha, N | 1 |
5 other study(ies) available for sorafenib and silicon
Article | Year |
---|---|
Copper-free azide-alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake.
Topics: Alkynes; Antineoplastic Agents; Azides; Cell Line, Tumor; Cell Proliferation; Click Chemistry; Cycloaddition Reaction; Drug Carriers; Humans; Nanoparticles; Neoplasms; Niacinamide; Phenylurea Compounds; Porosity; Silicon; Sorafenib | 2014 |
Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Delayed-Action Preparations; Drug Delivery Systems; Endocytosis; Humans; Methotrexate; Nanoparticles; Niacinamide; Particle Size; Phenylurea Compounds; Porosity; Silicon; Sorafenib; Spectroscopy, Fourier Transform Infrared; Static Electricity | 2015 |
Multifunctional porous silicon nanoparticles for cancer theranostics.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Humans; Male; Mice, Nude; Nanoparticles; Neoplasms; Niacinamide; Phenylurea Compounds; Silicon; Sorafenib; Theranostic Nanomedicine | 2015 |
Cyclodextrin-Modified Porous Silicon Nanoparticles for Efficient Sustained Drug Delivery and Proliferation Inhibition of Breast Cancer Cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclodextrins; Drug Delivery Systems; Drug Liberation; Female; Flow Cytometry; Humans; Kidney; Liver; Nanoparticles; Niacinamide; Particle Size; Phenylurea Compounds; Porosity; Rats; Silicon; Sorafenib; Spectroscopy, Fourier Transform Infrared | 2015 |
Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles.
Topics: Antineoplastic Agents; Cell Line; Click Chemistry; Cross-Linking Reagents; Delayed-Action Preparations; DNA; Drug Liberation; Fluoresceins; Fluorescent Dyes; Humans; Maleic Anhydrides; Nanocomposites; Nanoparticles; Niacinamide; Oxidation-Reduction; Phenylurea Compounds; Polyethyleneimine; Polyvinyls; Porosity; Silicon; Sorafenib | 2017 |